A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded by a grant from the Council of Medical Specialty Societies (CMSS) awarded to the SVS, the event aims to expand physician knowledge and improve clinical confidence in treating CLTI.
The breakfast event, scheduled for 7 a.m. Central Time on Saturday, June 22, will focus on individualizing treatment recommendations for CLTI patients. It will emphasize staging and setting patient expectations to facilitate better decision-making. The session will review the importance of using the Vascular Quality Initiative (VQI) CLTI risk calculator, Wound, Ischemia and foot Infection (WIfI) classification and Global Anatomic Staging System (GLASS) to guide treatment, along with vein mapping and angiography.
“The goal of this session is to equip physicians with the tools and knowledge needed to engage in meaningful, informed conversations with their patients about CLTI,” said Michael Conte, MD, professor and division chief of Vascular and Endovascular Surgery at the University of California, San Francisco. “By focusing on the PLAN (Patient risk, Limb severity, ANatomic complexity of disease) algorithm, we can set expectations and treatment plans to individual patient needs.”
The event aims to provide a practical framework for enhancing clinical practice and patient interactions. Participants will also learn effective communication strategies for engaging with patients. This patient-centered approach aims to improve clinical confidence and effectiveness in treating CLTI. To register, visit vascular.org/informedCLTI.
